Journey Medical
DERM
14 hedge funds and large institutions have $8.76M invested in Journey Medical in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
15.27% more ownership
Funds ownership: 0% → 15.27% (+15%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BRF
B. Riley Financial
Los Angeles,
California
|
+$6.26M |
| 2 |
Neuberger Berman Group
New York
|
+$1.44M |
| 3 |
AFG
American Financial Group
Cincinnati,
Ohio
|
+$1.3M |
| 4 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$1.02M |
| 5 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$825K |
Top Sellers
DERM Hedge Fund Activity: Q4 2021 in Review
14 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Journey Medical (DERM) for Q4 2021, worth a combined $8.76M.
Buyers outnumbered sellers: 14 funds opened new DERM positions and 0 closed out — a net gain of 14 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was B. Riley Financial, opening a new position worth an estimated $6.26M.
- 14 institutional investors held Journey Medical (DERM) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $8.76M of Journey Medical stock for Q4 2021.
- 14 funds opened new Journey Medical positions in Q4 2021 and 0 closed out, a net change of +14 holders.
- The largest Journey Medical buyer in Q4 2021 was B. Riley Financial, an estimated $6.26M added.
Based on aggregated 13F filings for Q4 2021.